Shanghai Pharmaceuticals Holding Co. Ltd. (S1R)
Market Open
11 Aug, 08:31
XFRA 
€
1. 25
0
0%
€
4.45B Market Cap
- P/E Ratio
0.06% Div Yield
11 Volume
0 Eps
€ 1.25
Previous Close Want to track S1R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
S1R trading today higher at €1.25, an increase of 0% from yesterday's close, completing a monthly increase of 2.459% or €0.03. Over the past 12 months, S1R stock gained 0.8065%.
S1R pays dividends to its shareholders, with the most recent payment made on Feb 06, 2026. The next announced payment will be in In 1 weeks on Aug 24, 2026 for a total of €0.405.
The last earnings report, released on Apr 27, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0733%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on HKEX (HKD).
S1R Chart
Shanghai Pharmaceuticals Holding Co. Ltd. (S1R) FAQ
What is the stock price today?
The current price is €1.25.
On which exchange is it traded?
Shanghai Pharmaceuticals Holding Co. Ltd. is listed on XFRA.
What is its stock symbol?
The ticker symbol is S1R.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.06%.
What is its market cap?
As of today, the market cap is 4.45B.
Has Shanghai Pharmaceuticals Holding Co. Ltd. ever had a stock split?
No, there has never been a stock split.
Shanghai Pharmaceuticals Holding Co. Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | - CEO | XFRA Exchange | CNE1000012B3 ISIN |
| China Country | 49,402 Employees | 14 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Shanghai Pharmaceuticals Holding Co. Ltd. is a comprehensive pharmaceutical company engaged in both the production and distribution of pharmaceuticals in China. It operates through multiple divisions primarily focusing on pharmaceutical manufacturing, distribution, and retail. The company's primary function is to develop a wide array of pharmaceuticals, including chemical drugs, traditional Chinese medicines, and medical devices. Its products cater to various healthcare needs and are critical to the medical industry across the region. Notably, the company extends its reach beyond local markets, actively engaging in international collaborations to innovate and expand its product line. Shanghai Pharmaceuticals plays a significant role in the healthcare sector by ensuring the availability and accessibility of essential medicines, supporting China's expansive healthcare infrastructure. The company is also a pivotal part of China's efforts to enhance its pharmaceutical industry, contributing to the sector's growth and development in line with global standards. As one of the leading pharmaceutical firms in Asia, Shanghai Pharmaceuticals Holding Co. Ltd. continues to influence healthcare trends and practices.
Contact Information
Address: Shanghai Pharmaceutical Building
Phone: 86 21 6373 0908
Website: https://www.sphchina.com
